TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions.
In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.
Mar 10, 2021: TFF Pharmaceuticals Fourth Quarter and Full-Year 2020 Financial and Business Results Conference
TFF Pharmaceuticals Corporate Overview – March 2020
TFF Pharmaceuticals Awarded Contract under DARPA’s Next-Generation Personalized Protective Biosystems Program for U.S. Warfighters
April 13, 2021
March 26, 2021
March 10, 2021